Development of Precision method for Pandu

Development of Precision method and its validation by assessing to effect of Punarnava (Boerhaavia diffusa Linn.) in Pandu - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/08/056119

Enrollment

Registered

2023-08-04

Start date

Unknown

Completion date

Unknown

Last updated

2024-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R688- Other general symptoms and signs

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: symptoms of Pandu: Panduta(Paleness) Hridaspandana(Palpitation), Daurbalya(Weakness) Group A: Vata dominant symptoms Pindikodwestana (cramps in the calf muscle), Rukshata (Dryness of skin), Angamarda (Body ache), Kampa (Trembling) Group B: Kapha dominant symptoms Gaurava (Heaviness), Bhrama (Vertigo), Klama (Mental fatigue), Aalasya (Laziness), Aruchi (Anorexia)

Exclusion criteria

Exclusion criteria: 1. Age 30 years 2. Uncontrolled clinical conditions like HTN, cancer, HIV, HBsAg, Liver cirrhosis, Cardiac failure, Stroke, etc. 3. History of Metabolic disorder 4. Anemia with any associated severe complication

Design outcomes

Secondary

Measure	Time frame
Hridaspandana(Palpitation), Panduta(Paleness),Angamarda (Bodyche),Rukshata(Dryness), Aruchi(Anorexia), Gaurava(Heaviness) Timepoint: 3 week	—

Primary

Measure	Time frame
Daurbalya(Weakness) Timepoint: 3 week	—

Countries

India

Contacts

Public ContactDr Suman Singh

Govt.Ayurvedic college Vadodara

drdilipjn@gmail.com9925941861

Outcome results